You are here: Industry Insights > SMC

News List

SMC suggests three new medicines for routine use europeanpharmaceuticalreview
August 14, 2017
SMC has published advice accepting 3 new medicines for regular use by NHS Scotland.
SMC approves Amgen’s carfilzomib for multiple myeloma treatment pharmaceutical-technology
August 10, 2017
The Scottish Medicines Consortium (SMC) has approved the routine use of Amgen’s carfilzomib (Kyprolis), in combination with dexamethasone, for the treatment of multiple myeloma across National Health Service (NHS) Scotland.
SMC recommends three new medicines pharmatimes
August 08, 2017
The Scottish Medicines Consortium (SMC) has accepted three new medicines for routine use by NHS Scotland.
SMC rejects Perjeta (pertuzumab) for NHS use for breast cancer europeanpharmaceuticalreview
June 19, 2017
The Scottish Medicines Consortium (SMC) has made a final decision to turn down Perjeta (pertuzumab) for routine NHS funding for first line use in women whose HER2-positive breast cancer has returned to the breast but is inoperable, or where it has spread
SMC rejects Perjeta (pertuzumab) for NHS use for breast cancer europeanpharmaceuticalreview
June 16, 2017
The Scottish Medicines Consortium (SMC) has made a final decision to turn down Perjeta (pertuzumab) for routine NHS funding for first line use in women whose HER2-positive breast cancer has returned to the breast but is inoperable
SMC approves anti-HIV drug PrEP pharmaceutical-technology
April 14, 2017
The Scottish Medicines Consortium (SMC) has approved the treatment known as Pre Exposure Prophylaxis (PrEP) that reduces the chances of being infected with HIV.

Previous page 1 2 3 4 Next page